QuantRx Biomedical Corporation
QTXB
$0.0005
$0.0003150.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.40K | 45.60K | 41.90K | 43.30K | 45.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.40K | 45.60K | 41.90K | 43.30K | 45.80K |
| Operating Income | -44.40K | -45.60K | -41.90K | -43.30K | -45.80K |
| Income Before Tax | -260.50K | -262.30K | -258.50K | -260.00K | -262.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.26 | -0.26 | -0.26 | -0.26 | -0.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -260.50K | -262.30K | -258.50K | -260.00K | -262.60K |
| EBIT | -44.40K | -45.60K | -41.90K | -43.30K | -45.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 314.79M | 314.79M | 314.79M | 314.79M | 314.79M |
| Average Diluted Shares Outstanding | 314.79M | 314.79M | 314.79M | 314.79M | 314.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
